Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05206227 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Histamine as a Molecular Transducer of Adaptation to Exercise

StatusActive, Not Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 31, 2026 to Mar 31, 2027
    • Site details revised
    v10
  2. 3 versions Re-verified since Nov 13, 2024, no change to tracked fieldsv7-v9
  3. Study completion date: Mar 31, 2026 to Dec 31, 2026v6
  4. Primary endpoints: 3 to 4
    • Interventions: Aerobic Exercise (Behavioral), Resistance and Aerobic Exercise (Behavioral), alpha-FMH (Drug) to Aerobic Exercise (Behavioral), Antihistamine (Drug), Resistance and Aerobic Exercise (Behavioral), alpha-FMH (Drug)
    • Study arms: 3 to 4
    v5
  5. Phase: Not applicable to Early Phase 1v4 Show 6 more changesShow less
    • Enrollment target: 20 to 80
    • Primary completion date: Dec 31, 2023 to Dec 31, 2025
    • Primary endpoints: 1 to 3
    • Interventions: Exercise (Behavioral) to Aerobic Exercise (Behavioral), Resistance and Aerobic Exercise (Behavioral), alpha-FMH (Drug)
    • Study arms: 1 to 3
    • Study description shortened, about 2 words
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Primary endpoint revised
    • Start date changed from estimate of Feb 1, 2022 to Jul 28, 2021
    • Study description expanded, about 1 word
    • Study title shortened, about 2 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is investigating the role of histamine in generating adaptation to exercise
Trial Details
NCT Number NCT05206227
Lead Sponsor University of Oregon
Conditions
(from sponsor)		 Postexercise Hypotension
Related terms Motor Activity, Post-Exercise Hypotension
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov